Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

To evaluate if naltrexone plus ketamine is effective in reducing depression and alcohol consumption.

Topic Depression Addiction Alcohol Use Disorder
Compound Ketamine
Country United States of America
Visit trial
Status Completed
Results Published No
Start date 05 January 2016
End date 05 January 2018
Chance of happening 100%
Phase Phase II
Design Open
Type Interventional
Generation First
Participants 5
Sex All
Age 21- 65
Therapy No

Trial Details

The primary goal of this proposal is to test naltrexone plus repeated ketamine treatment for major depressive disorder and alcohol use disorder in an open-label trial.

NCT Number NCT03658330

Measures Used

Montgomery-Asberg Depression Rating Scale
A ten-item diagnostic questionnaire used to measure the severity of depressive symptoms in patients with mood disorders.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.